# Accelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma.

> **NCT07058116** · PHASE1 · RECRUITING · sponsor: **Neutron Therapeutics, LLC** · enrollment: 10 (estimated)

## Conditions studied

- Head and Neck Carcinoma

## Interventions

- **DRUG:** L-Boronophenylalanine intravenous administration

## Key facts

- **NCT ID:** NCT07058116
- **Lead sponsor:** Neutron Therapeutics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-08
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-01-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07058116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07058116, "Accelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07058116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*